Flare Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
215 1st St Ste 150, Cambridge, Massachus...Phone Number
(857) 706-4400Website
www.flaretx.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Flare Therapeutics
Based in Cambridge, MA, Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flares team has uncovered switch sites, druggable regions that are key targets for transcription factor regulation to address mutations that cause disease. The company was founded in 2021.Explore more
Flare Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Flare Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Flare Therapeutics is spiking on competitors!
Click to see if Flare Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Flare Therapeutics recently announced quarterly report
Check if Flare Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Flare Therapeutics has new funding data
Product Launch: Get notified when Flare Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Flare Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Flare Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Flare Therapeutics
Compare insights from companies similar to Flare Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Flare Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Flare Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Flare Therapeutics.
Flare Therapeutics financials insights
Gather financial insights about Flare Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$82M
2023
Series B
$123M
2026
Series C
$85M
Flare Therapeutics Tech Stack
A closer look at the technologies used by Flare Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Flare Therapeutics News & Media
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
- Proceeds will fund advancement of ARON degrader, FX-111, to proof of concept and preclinical development of ARON RIPTAC programFlare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026
CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that it will present three posters at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026, which is being held from April 17-22, 2026, in San Diego, CA.Flare Therapeutics Inc. Partners with Simplicis to Eliminate "Single-Point-of-Failure" Risks in Compound Management
By adopting Simplicis Ledger™, Flare Therapeutics replaces manual "human-babysitting" of data with automation-ready infrastructure to scale life sciences R&D. CAMBRIDGE, Mass., March 2, 2026 /PRNewswire/ -- Simplicis, a provider of modern sample and inventory management software for life...Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium
Data support emergence of differentiating clinical benefit with a favorable safety and tolerability profile for patients with advanced UC Data support emergence of differentiating clinical benefit with a favorable safety and tolerability profile for patients with advanced UC
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Flare Therapeutics
Sign Up For FreeTo access detailed company insights
Based in Cambridge, MA, Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flares team has uncovered switch sites, druggable regions that are ke... Read More
